A 2001 surge in proteomics investment has generated record revenues, seeding a burgeoning job market and a flowering of training courses and research resources. Proteomics revenues grew 41.9% from $963 million to $1.37 billion (US), in 2001, according to Frost & Sullivan, a San Antonio, Texas-based investment firm. Most of the revenues are from sales of laboratory instruments and supplies, now leaving these fully equipped labs needing to hire staff to use the tools. "We have all this wonderful equipment, but now we need people to do actual work," says Jochen Kruip, head of proteomics in the Frankfurt, Germany, office of Aventis.

According to Kruip, Aventis seeks people with skills in mass spectrometry and protein and peptide chromatographic separation, but as proteomics continues to evolve, so does the definition of a qualified worker. "Right now there is no such thing as a proteomicist," says David Jensen, scientific recruiter...

Interested in reading more?

Magaizne Cover

Become a Member of

Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member?